SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-056166
Filing Date
2024-06-26
Accepted
2024-06-26 16:01:28
Documents
18
Period of Report
2024-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208314-8k_elevai.htm   iXBRL 8-K 36704
2 AMENDED AND RESTATED CONSULTING AGREEMENT, BY AND BETWEEN THE COMPANY AND GB CAP ea020831401ex10-1_elevai.htm EX-10.1 33711
3 AMENDED AND RESTATED CONSULTING AGREEMENT, BY AND BETWEEN THE COMPANY AND NORTHS ea020831401ex10-2_elevai.htm EX-10.2 30465
4 CHAIRMAN APPOINTMENT LETTER TO MR. BRAEDEN LICHTI ea020831401ex10-3_elevai.htm EX-10.3 38858
5 TERMINATION AGREEMENT BY AND BETWEEN THE COMPANY AND MR. LICHTI ea020831401ex10-4_elevai.htm EX-10.4 30504
6 GRAPHIC ex10-3_001.jpg GRAPHIC 3166
  Complete submission text file 0001213900-24-056166.txt   390703

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE elab-20240620.xsd EX-101.SCH 3033
8 XBRL LABEL FILE elab-20240620_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE elab-20240620_pre.xml EX-101.PRE 22371
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0208314-8k_elevai_htm.xml XML 3795
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 241073384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)